Abstract
Background: The extensive involvement of interleukin enhancer binding factor 2 (ILF2) in RNA stability and inflammation response is well documented. Aberrant LncRNAs expression contributes to psoriasis development and progression. However, little is known about the role of ILF2 in psoriasis. Objectives: Aimed to explore the role of ILF2 and KLHDC7B-DT in psoriasis. Methods: Long noncoding RNA (lncRNA) expression in psoriatic tissues was measured by lncRNA microarray and qRT-PCR. Normal human epidermal keratinocytes (NHEKs), HaCaT cells, and Ker-CT cells stimulated by M5 (IL-17A, IL-22, IL-1 α, oncostatin M, and TNF-α) were used to establish a psoriasis model in vitro.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
